Cutaneous gene expression of plasmid DNA in excised human skin following delivery via microchannels created by radio frequency ablation

被引:43
作者
Birchall, J [1 ]
Coulman, S
Anstey, A
Gateley, C
Sweetland, H
Gershonowitz, A
Neville, L
Levin, G
机构
[1] Cardiff Univ, Welsh Sch Pharm, Gene Delivery Res Grp, Cardiff CF10 3XF, Wales
[2] Royal Gwent Hosp, Gwent Healthcare NHS Trust, Newport NP20 2UB, Gwent, Wales
[3] Cardiff Univ, Sch Med, Cardiff CF14 4XN, Wales
[4] TransPharma Med Ltd, IL-71291 Lod, Israel
关键词
radiofrequency-microchannels; radiofrequency ablation; plasmid DNA; skin; gene therapy;
D O I
10.1016/j.ijpharm.2005.12.036
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The skin is a valuable organ for the development and exploitation of gene medicines. Delivering genes to skin is restricted however by the physico-chemical properties of DNA and the stratum corneum (SC) barrier. In this study, we demonstrate the utility of an innovative technology that creates transient microconduits in human skin, allowing DNA delivery and resultant gene expression within the epidermis and dermis layers. The radio frequency (RF)-generated microchannels were of sufficient morphology and depth to permit the epidermal delivery of 100 nm diameter nanoparticles. Model fluorescent nanoparticles were used to confirm the capacity of the channels for augmenting diffusion of macromolecules through the SC. An ex vivo human organ culture model was used to establish the gene expression efficiency of a beta-galactosidase reporter plasmid DNA applied to ViaDerm (TM) treated skin. Skin treated with ViaDerm (TM) using 50 mu m electrode arrays promoted intense levels of gene expression in the viable epidermis. The intensity and extent of gene expression was superior when ViaDerm (TM) was used following a prior surface application of the DNA formulation. In conclusion, the RF-microchannel generator (ViaDerm (TM)) creates microchannels amenable for delivery of nanoparticles and gene therapy vectors to the viable region of skin. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 39 条
[1]  
BARRY B W, 1987, Journal of Controlled Release, V6, P85, DOI 10.1016/0168-3659(87)90066-6
[2]   A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression [J].
Bins, AD ;
Jorritsma, A ;
Wolkers, MC ;
Hung, CF ;
Wu, TC ;
Schumacher, TNM ;
Haanen, JBAG .
NATURE MEDICINE, 2005, 11 (08) :899-904
[3]   Physico-chemical characterisation and transfection efficiency of lipid-based gene delivery complexes [J].
Birchall, JC ;
Kellaway, IW ;
Mills, SN .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 183 (02) :195-207
[4]  
Birchall JC, 2005, POLYMERIC GENE DELIVERY: PRINCIPLES AND APPLICATIONS, P573
[5]   Electroporation enhances transfection efficiency in murine cutaneous wounds [J].
Byrnes, CK ;
Malone, RW ;
Akhter, N ;
Nass, PH ;
Wetterwald, A ;
Cecchini, MG ;
Duncan, MD ;
Harmon, JW .
WOUND REPAIR AND REGENERATION, 2004, 12 (04) :397-403
[6]   Microfabricated silicon microneedles for nonviral cutaneous gene delivery [J].
Chabri, F ;
Bouris, K ;
Jones, T ;
Barrow, D ;
Hann, A ;
Allender, C ;
Brain, K ;
Birchall, J .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (05) :869-877
[7]   INVIVO PROMOTER ACTIVITY AND TRANSGENE EXPRESSION IN MAMMALIAN SOMATIC TISSUES EVALUATED BY USING PARTICLE BOMBARDMENT [J].
CHENG, L ;
ZIEGELHOFFER, PR ;
YANG, NS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) :4455-4459
[8]   Enhanced cutaneous gene delivery following intradermal injection of naked DNA in a high ionic strength solution [J].
Chesnoy, S ;
Huang, L .
MOLECULAR THERAPY, 2002, 5 (01) :57-62
[9]   Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis [J].
Dean, HJ ;
Fuller, D ;
Osorio, JE .
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2003, 26 (5-6) :373-388
[10]   Topical gene transfer into rat skin using electroporation [J].
Dujardin, N ;
Van der Smissen, P ;
Préat, V .
PHARMACEUTICAL RESEARCH, 2001, 18 (01) :61-66